Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 6.1525.42108.7630.47-21.08

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 6.15 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20256.15
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2025 6.15
-75.81
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,538.2 Cr -2% -8.2% -22.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,343.0 Cr -0.2% 5.8% 0.9% Stock Analytics
DIVIS LABORATORIES ₹171,774.0 Cr -0.6% -5.2% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,665.0 Cr -0.5% 2.5% 12.1% Stock Analytics
CIPLA ₹122,878.0 Cr -1.1% -0.2% -1.2% Stock Analytics
DR REDDYS LABORATORIES ₹106,581.0 Cr 2.4% 7% 6.2% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-2%

-8.2%

-22.3%

SENSEX

-0.5%

1.5%

6.9%


You may also like the below Video Courses